Download Unicorn Signals App

By EquityPandit

MARKETS

Laurus Labs Shares Extend Gains as USFDA Approves HIV Drug

The company will address the aforementioned observation within the given time frame.

Shares of Laurus Labs closed more than 1% on May 2, extending gains from another session after the US health regulator approved its HIV drug. The stock had risen more than 6% in the previous two sessions.

The pharmaceutical and biotech company told exchanges it had received preliminary approval from the USFDA for the world’s first orally dispersible film (ODF) for the paediatric ARV (antiretroviral) treatment Dolutegravir.

This would provide significant benefits regarding adherence to ARV drug therapy in paediatric HIV treatment.

Laurus Labs is also the first company to receive generic approval for the abacavir/dolutegravir/lamivudine fixed-dose combination for the second-line treatment of adult HIV patients.

Founder and CEO Satyanarayana Chava said, “This option will facilitate strict compliance and adherence to HIV treatment and benefit caregivers.”

The stock closed 1.3% higher at Rs 311.60 on the National Stock Exchange, with 4.55 million shares traded, up from a gain of more than 5% in the previous session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.
MARKETS

Zydus Life Ahmedabad Unit Clears USFDA Inspection 

Ali Waghbakriwala

Zydus Lifesciences Ltd announced on Friday that the United States Food and Drug Administration (USFDA) has successfully completed an inspection of its Ahmedabad facility without any observations.

The US health regulator inspected the company’s Topical Manufacturing site in Changodar, Ahmedabad, as part of a routine surveillance inspection conducted between February 10 and February 14. The inspection concluded with zero observations, the company stated in a press release.

Meanwhile, Zydus Lifesciences reported strong financial performance in Q3 FY25. The company’s net profit surged 30% year-on-year (YoY) to Rs 1,023 crore for the quarter ending December 31, 2024, compared to Rs 789 crore in the same period last year. This profit growth was primarily driven by a sharp rise in forex gains, which jumped 771.42% YoY to Rs 183 crore from Rs 21 crore a year ago.

The company’s revenue for the December 2024 quarter increased 17% YoY to Rs 5,269 crore. US formulation sales grew 29% YoY to $285 million, surpassing the estimated $270 million, with the US market contributing nearly 47% to Zydus Lifesciences’ total revenue.

Additionally, the company’s EBITDA rose 25.9% YoY to Rs 1,387 crore in Q3 FY25, up from Rs 1,102 crore in the previous year. The EBITDA margin expanded by nearly 200 basis points (bps) to 26.3% from 24.5% in the same period last year.

Sharvil Patel, Managing Director of Zydus Lifesciences, said, “Our robust portfolio execution in the US, market share gain in focused therapy segments and brands in India, and strategic leveraging of our global portfolio in international markets position us well for future growth.”

At 3:30 pm, the shares of Zydus Lifesciences closed 4.62% lower at Rs 899.30 on NSE.

Navigate Zydus Lifesciences Like a Pro. Ask the Analyst.

Feeling overwhelmed by the markets? Let Unicorn Signals be your guide. Our user-friendly app simplifies complex data and provides actionable trading signals. Download the app today and trade with confidence!

MARKETS

ITI Shares Hit 5% Lower Circuit on Weak Q3 Earnings 

Ali Waghbakriwala

Shares of ITI Ltd hit the 5% lower circuit on Friday 14 February after the company announced its quarterly earnings for October-December. 

The state-owned telecom product manufacturer reported a net loss of Rs 48.9 crore for the December quarter, contracting from Rs 101.3 crore for the same period last year.

The revenue from operations of the company stood at Rs 1,034.5 crore, marking a 299.73% year-on-year increase from Rs 258.8 crore reported in the same quarter last year, driven by strong operational performance regardless of increasing raw material cost. 

Among the major factors influencing the company’s success in FY24 were projects including ASCON Phase IV, BSNL 4G Rollout, Mahanet, TanfiNet, NFS Project, Gujnet, and IAF project for upgrading the 3G network to 4G/5G.

In addition, the company announced other order wins, including a Rs 95 crore project from the Directorate of Geology & Mining of the Uttarakhand government. The company, together with its consortium partner, has secured the lowest bid for BharatNet project packages valued at Rs 4,559 crore.

The company’s earnings before interest, tax, depreciation, and amortisation (EBITDA) loss was Rs 10.6 crore, as opposed to the Rs 43.5 crore loss in the third quarter of the previous year.

At 3:30 pm, the shares of ITI closed 4.99% lower at Rs 270.15 on NEE.

ITI Ltd Insights? Let the Analyst Guide You.

Tired of guessing stocks to trade in daily?
Unicorn Signals empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more. Download the Unicorn Signals app today and take control of your investments!

MARKETS

GAIL (India) Inks an MoU with Accelera by Cummins; Shares Gain 

Ali Waghbakriwala

Shares of state-owned GAIL(India) Ltd were trading almost 2% higher on 14 February after the company announced signing a Memorandum of Understanding (MoU) with Cummins Inc.’s zero-emissions branch, Accelera by Cummins to collaborate on clean energy and energy transition solutions in India.

The agreement was formally signed in New Delhi at the ongoing India Energy Week 2025, according to a GAIL stock exchange release.

The state-owned energy firm informed the stock markets that the collaboration will explore a variety of green energy opportunities, including hydrogen generation, blending, transportation, and storage, by using Accelera’s expertise in innovative energy solutions and GAIL’s well-established natural gas infrastructure.

GAIL, a well-known Maharatna CPSE under the Ministry of Petroleum and Natural Gas, moves closer to its “net zero” goals of 2040 to 2035, this partnership marks a major step forward in India’s energy transition efforts.

Cummins Inc. offers a wide range of products, including fuel cells, electric and hybrid solutions, batteries, electric power generation systems, advanced powertrains, and hydrogen production technologies.

GAIL has been at the forefront of renewable energy projects for a long time. In April 2024, the company installed a 10 MW Green Hydrogen unit at its Vijaipur plant in Madhya Pradesh’s Guna District. The electrolyzer was supplied by Cummins’ Accelera.

Additionally, GAIL plans to expand its successful hydrogen mixing pilot program in CNG/PNG networks.

The company has also set up a 5 TPD Compressed Biogas (CBG) factory in Ranchi, with plans to construct 26 more units throughout India in the upcoming three to four years.

GAIL intends to establish ten CBG plants in partnership with Leafiniti Bioenergy and to develop Synthetic Natural Gas in West Bengal in partnership with Coal India. Furthermore, the PSU has established a joint venture to build a 500 KLPD, 1G grain-based ethanol plant in Rajasthan.

At 1:23 pm, the shares of GAIL (India) were trading 0.17% lower at Rs 162.04 on NSE. 

Wondering About GAIL (India)? The Analyst Has Answers.

Ready to invest like a pro? Unicorn Signals app equips you with 100+ Free tools and knowledge you need to succeed. Download the Unicorn Signals app and gain access to daily stock lists and insightful market analysis and much more!

MARKETS

Premier Energies Shares Gain 1% on Securing Contract for Solar Modules 

Ali Waghbakriwala

Shares of Premier Energies Ltd were trading in the green and 1% higher on 14 February after the company announced that they had received an order for delivering solar PV modules for Rs 1,234 crore.

The supply of these modules is anticipated to begin in April 2025.

Premier Energies said that its existing clientele had placed two orders.

The government has recently bolstered its support for the business with several programs, which has helped it, among other things, to ward off Chinese competition.

Even if they are significant, the current import limitations are still quite minimal. The proposed regulations would effectively limit domestic competition to Indian manufacturers of solar integrated cells and modules after June 2026.

Separately, Indian manufacturers are reaping the benefits of future export markets, especially in the United States.

Over the next two years, it is expected that Premier Energies will raise its existing 2GW and 3GW cell and module capabilities to 7GW and 8GW, respectively. Consequently, earnings are expected to grow at a 90% CAGR in FY24–27E.

Integrated solar cells and solar panels are manufactured by Premier Energies. Products offered by the company include solar modules, monofacial and bifacial modules, cells, O&M solutions, and EPC solutions.

However, at 12:39 pm, the shares of Premier Energies shed all their early gains and were trading 3.55% higher at Rs 964.70 on NSE.

Curious About Premier Energies? Ask the Analyst.

Discover the next big investment! Unicorn Signals’ IPO screener helps you identify promising initial public offerings. Download Unicorn Signals and get ahead of the curve! Sign Up Now & Find Your Next IPO Gem!

MARKETS

Stocks in Focus: Hindustan Aeronautics, Adani Green Energy, United Breweries, and Others

Ali Waghbakriwala

The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 0.42% lower by 97 points at 22,998.5, indicating that the domestic benchmark indices are likely to make a negative start on Friday. 

On Thursday, 13 February, Domestic benchmark indices S&P BSE Sensex slumped by 32.11 points or 0.04% and settled at 76,138.97 while the Nifty50 traded 0.06% lower by 13.85 points, settling at 23,031.40.

Here are some stocks that are likely to remain in focus on 14 February.

Quarterly Results Today: Easy Trip Planners, GlaxoSmithKline Pharmaceuticals, Samvardhana Motherson International, Glenmark Pharmaceuticals, Aditya Birla Fashion and Retail, Dr Agarwals Eye Hospital, RateGain Travel Technologies, Swan Energy, and Zen Technologies are some of the prominent companies set to announce their quarterly earnings for October-December. 

Hindustan Aeronautics: The company has signed an agreement with Saab, a global defence company that manufactures laser warning systems. 

Adani Green Energy: The company has announced its plans to withdraw from its $1 billion wind energy project in Sri Lanka, citing unresolved environmental clearance and a Supreme Court case as reasons for its action. 

United Breweries: In its quarterly earnings for October-December, the company reported a 55% year-on-year decline in net profit to Rs 38.3 crore for the quarter under review compared to Rs 84.9 crore reported in the same quarter last year. 

NTPC: The company announced that they are in talks with foreign firms in Russia and the US for the construction of small nuclear reactors. 

UltraTech Cement: The company has announced the commissioning of 0.6 mtpa slag-based grinding capacity at its Karur, Tamil Nadu unit, taking the total capacity of the plant to 3.30 mtpa. 

Bank of Baroda: The Board of Directors of the company have approved raising funds in tune to Rs 8,500 crore via Qualified Institutional Placement (QIP) in multiple tranches up to March 2028.

Tata Consultancy Services: The company has announced that it is signing an agreement with UPM to drive UPM’s end-to-end IT transformation. This agreement will help drive growth for UPM, boost the adoption of an AI-first operating model, and enhance the user experience. 

Nazara Technologies: For the quarter ended 31 December, the company reported a 53.6% YoY decline in consolidated net profit to Rs 113.68 crore for the quarter compared to Rs 29.52 crore net profit reported in the same quarter of the previous fiscal year. 

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

Latest
IPO
Weekly
Outlook

Stock
Market
Prediction